Sunnyvale, CA, July 27, 2007
IMPAC Medical Systems, Inc., has been selected to participate in
the American Society of Clinical Oncology’s (ASCO) Electronic
Health Records (EHR) 2007 Oncology Symposium: Providing You with
Tools to Make an EHR Decision for Your Practice, September
19-20, in Dallas, Texas.
IMPAC, an Elekta company, has been working with ASCO throughout
the last six months to adopt the association’s recommendations
on functional elements for the development of an oncology
treatment care plan and summary. Functional and clinical
elements developed for ASCO's treatment plan and treatment
summary are available at www.asco.org/ehr, select EHR Events,
then EHR Roundtable. IMPAC also is pleased to be one of only
seven of the original 23 vendors invited to participate in the
symposium.
The EHR Symposium will offer a setting for oncologists,
administrators, nurses and other members of the oncology care
team to evaluate EHR software that may be a good fit for their
environment. Vendors participating in the symposium will conduct
oncology-specific product demonstrations based on scenarios
provided by ASCO; and on Day 2, vendors will participate in a
head-to-head "face-off" event. Educational opportunities at the
symposium will include sessions on EHR implementation, improving
practice efficiency with EHRs, the EHR return on investment and
more.
Additional information regarding ASCOs 2007 EHR Symposium is
available online at:
www.asco.org/ehr.
About the
American Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO) is
the world’s leading professional organization representing
physicians of all oncology subspecialties who care for people
with cancer. ASCOs nearly 25,000 members from the United States
and abroad set the standard for patient care and lead the
efforts to discover more effective cancer treatments, increase
funding for clinical and translational research, and,
ultimately, improve cancer care for the estimated 10 million
people diagnosed with cancer worldwide each year.
ASCO publishes the Journal of Clinical Oncology (JCO), the
preeminent, peer-reviewed, medical journal on clinical cancer
research, and produces People Living with Cancer (www.plwc.org),
a comprehensive consumer website providing oncologist-vetted
cancer information to help patients and families make informed
health-care decisions.
About
Elekta and IMPAC
Elekta Inc., IMPAC Medical Systems, Medical Intelligence and 3D
Line Medical Systems are all part of the Elekta Group, an
international medical technology corporation, providing
meaningful solutions, comprehensive information systems and
services for improved cancer care and management of brain
disorders.
All of Elekta’s solutions employ non-invasive or minimally
invasive techniques and are therefore clinically effective,
gentle on the patient and cost-effective. Elekta is listed on
the Nordic Exchange under the ticker EKTAb and the company head
office is located in Stockholm, Sweden. For additional
information, please visit
www.elekta.com
and
www.impac.com. |
|
Media Inquiries:
Michelle Lee
PR and Advertising Manager
Tel: +1 770-670-2447
michelle.lee@elekta.com
Link Disclaimer
|
